Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...
US pharma giants eye India’s obesity crisis with pricey shots, sparking ‘Make in India’ and affordability debates ...
Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback